FDA Drug Application (202718) for MORPHINE SULFATE by TEVA PHARMS USA

Back to FDA Applications sponsored by TEVA PHARMS USA

Application Number202718
Product Number001
FormCAPSULE, EXTENDED RELEASE;ORAL
Dosage20MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameMORPHINE SULFATE
Active IngredientMORPHINE SULFATE



Back to FDA Applications sponsored by TEVA PHARMS USA

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.